27898506|t|Estimation of populational 24-h urinary sodium and potassium excretion from spot urine samples: evaluation of four formulas in a large national representative population
27898506|a|The aim of this study was to assess the validity of the estimation of 24-h urinary sodium (UNa) and urinary potassium (UK) excretion obtained through four formulae based on occasional urine samples. We analysed 2399 individuals (51% females) aged 18 to 96 years representatives of Portuguese population. Tanaka, Kawasaki, INTERSALT and NHANES formulae were used to predict 24-h UNa and UK excretion s from spot morning urinary samples (OUrS). We compared it with validated real 24-h urine samples (VUrS) (24-h UNa: 4052 ± 1432 mg/ day, 24-h UK = 2928 ± 1004 mg/ day). We compared observed vs. estimated measurements by examining bias (observed minus predicted UNa and UK), the correlation and intraclass correlation (ICC) coefficients between measurements, and Bland-Altman plots. We analysed the differences between observed and estimated Na and K excretion across subgroups defined by quintiles of observed Na and K excretion and subgroups defined hypertension status and control. The area under the ROC curve was used to assess the discriminatory capacity of formulas between high - intake salt individuals from low - intake individuals, taking the arbitrary values 3000 and 3900 mg/ day for, respectively, Na and K intake. Formulas produced significant mean bias for UNa: Kawasaki -1277, INTERSALT -569, NHANES -116 and for UK Tanaka -754, Kawasaki -95 mg/ day. Correlation coefficients were less than 0.360 and ICC coefficients were all less than 0.458 for both UNa and UK estimations. Bias varied across quintiles with overestimation of UNa at lower quintiles (by 29-105%) and underestimation at higher quintile (by 7-37%) regardless of formula. The Bland-Altman plots indicated a high dispersion of the estimates biases regardless of the formulae and normotension / hypertension condition particularly at higher levels. All formulas exhibited an area under the receiver operating characteristic curve below 0.67 both in normotensive individuals and hypertensive individuals. We found a poor agreement between estimated and observed measurements of UNa and UK in our large population. All these formulas incur in over - or underestimations of UNa and UK excretion that may be unreliable for clinical evaluation of individual's and mean population daily UNa and UK excretion.
27898506	0	10	Estimation	T081	C0750572
27898506	14	26	populational	T098	C1257890
27898506	32	46	urinary sodium	T123,T196	C1973436
27898506	51	60	potassium	T123,T196	C1971990
27898506	61	70	excretion	T039	C0221102
27898506	81	94	urine samples	T031	C1610733
27898506	81	94	urine samples	T031	C1610733
27898506	96	106	evaluation	T078	C1550157
27898506	115	123	formulas	T170	C0282574
27898506	144	158	representative	T098	C1257890
27898506	159	169	population	T098	C1257890
27898506	186	191	study	T062	C2603343
27898506	210	218	validity	T081	C2349101
27898506	226	236	estimation	T081	C0750572
27898506	245	259	urinary sodium	T123,T196	C1973436
27898506	261	264	UNa	T123,T196	C1973436
27898506	270	287	urinary potassium	T123,T196	C1971990
27898506	289	291	UK	T123,T196	C1971990
27898506	293	302	excretion	T039	C0221102
27898506	325	333	formulae	T170	C0282574
27898506	354	367	urine samples	T031	C1610733
27898506	386	397	individuals	T098	C0237401
27898506	403	410	females	T032	C0086287
27898506	412	416	aged	T032	C0001779
27898506	426	431	years	T079	C0439234
27898506	432	447	representatives	T098	C1257890
27898506	451	472	Portuguese population	T098	C0032730
27898506	474	480	Tanaka	T170	C0282574
27898506	482	490	Kawasaki	T170	C0282574
27898506	492	501	INTERSALT	T170	C0282574
27898506	506	521	NHANES formulae	T170	C0282574
27898506	548	551	UNa	T123,T196	C1973436
27898506	556	558	UK	T123,T196	C1971990
27898506	559	568	excretion	T039	C0221102
27898506	589	604	urinary samples	T031	C1610733
27898506	653	666	urine samples	T031	C1610733
27898506	680	683	UNa	T123,T196	C1973436
27898506	701	704	day	T079	C0439228
27898506	711	713	UK	T123,T196	C1971990
27898506	732	735	day	T079	C0439228
27898506	750	758	observed	T169	C1441672
27898506	763	772	estimated	T081	C0750572
27898506	773	785	measurements	T169	C0242485
27898506	799	803	bias	T078	C0242568
27898506	805	813	observed	T169	C1441672
27898506	830	833	UNa	T123,T196	C1973436
27898506	838	840	UK	T123,T196	C1971990
27898506	847	858	correlation	T080	C1707520
27898506	863	885	intraclass correlation	T081	C0392762
27898506	887	890	ICC	T081	C0392762
27898506	892	904	coefficients	T081	C1707429
27898506	913	925	measurements	T169	C0242485
27898506	931	949	Bland-Altman plots	T081	C0392762
27898506	967	978	differences	T080	C1705242
27898506	987	995	observed	T169	C1441672
27898506	1000	1009	estimated	T081	C0750572
27898506	1010	1012	Na	T123,T196	C0037473
27898506	1017	1018	K	T123,T196	C0032821
27898506	1019	1028	excretion	T039	C0221102
27898506	1036	1045	subgroups	T185	C1515021
27898506	1057	1066	quintiles	T201	C1508496
27898506	1070	1078	observed	T169	C1441672
27898506	1079	1081	Na	T123,T196	C0037473
27898506	1086	1087	K	T123,T196	C0032821
27898506	1088	1097	excretion	T039	C0221102
27898506	1102	1111	subgroups	T185	C1515021
27898506	1120	1139	hypertension status	T033	C0586110
27898506	1144	1151	control	T080	C0243148
27898506	1172	1181	ROC curve	T081	C0035787
27898506	1220	1228	capacity	T081	C1516240
27898506	1232	1240	formulas	T170	C0282574
27898506	1249	1253	high	T080	C0205250
27898506	1256	1262	intake	T169	C1512806
27898506	1263	1267	salt	T104	C0036140
27898506	1268	1279	individuals	T098	C0237401
27898506	1285	1288	low	T080	C0205251
27898506	1291	1297	intake	T169	C1512806
27898506	1298	1309	individuals	T098	C0237401
27898506	1322	1338	arbitrary values	T081	C0439183
27898506	1357	1360	day	T079	C0439228
27898506	1380	1382	Na	T123,T196	C0037473
27898506	1387	1388	K	T123,T196	C0032821
27898506	1389	1395	intake	T169	C1512806
27898506	1397	1405	Formulas	T170	C0282574
27898506	1432	1436	bias	T078	C0242568
27898506	1441	1444	UNa	T123,T196	C1973436
27898506	1446	1454	Kawasaki	T170	C0282574
27898506	1462	1471	INTERSALT	T170	C0282574
27898506	1478	1484	NHANES	T170	C0282574
27898506	1498	1500	UK	T123,T196	C1971990
27898506	1501	1507	Tanaka	T170	C0282574
27898506	1514	1522	Kawasaki	T170	C0282574
27898506	1531	1534	day	T079	C0439228
27898506	1536	1560	Correlation coefficients	T081	C0392762
27898506	1586	1589	ICC	T081	C0392762
27898506	1590	1602	coefficients	T081	C1707429
27898506	1637	1640	UNa	T123,T196	C1973436
27898506	1645	1647	UK	T123,T196	C1971990
27898506	1648	1659	estimations	T081	C0750572
27898506	1661	1665	Bias	T078	C0242568
27898506	1680	1689	quintiles	T201	C1508496
27898506	1695	1709	overestimation	T081	C0392762
27898506	1713	1716	UNa	T123,T196	C1973436
27898506	1720	1725	lower	T080	C0205251
27898506	1726	1735	quintiles	T201	C1508496
27898506	1772	1778	higher	T080	C0205250
27898506	1779	1787	quintile	T201	C1508496
27898506	1813	1820	formula	T170	C0282574
27898506	1826	1844	Bland-Altman plots	T081	C0392762
27898506	1857	1861	high	T080	C0205250
27898506	1862	1872	dispersion	T082	C0332624
27898506	1890	1896	biases	T078	C0242568
27898506	1915	1923	formulae	T170	C0282574
27898506	1928	1940	normotension	T033	C0243095
27898506	1943	1955	hypertension	T047	C0020538
27898506	1982	1988	higher	T080	C0205250
27898506	1989	1995	levels	T080	C0441889
27898506	2001	2009	formulas	T170	C0282574
27898506	2038	2077	receiver operating characteristic curve	T081	C0035787
27898506	2097	2109	normotensive	T033	C0243095
27898506	2110	2121	individuals	T098	C0237401
27898506	2126	2138	hypertensive	T033	C0857121
27898506	2139	2150	individuals	T098	C0237401
27898506	2186	2195	estimated	T081	C0750572
27898506	2200	2208	observed	T169	C1441672
27898506	2209	2221	measurements	T169	C0242485
27898506	2225	2228	UNa	T123,T196	C1973436
27898506	2233	2235	UK	T123,T196	C1971990
27898506	2249	2259	population	T098	C1257890
27898506	2271	2279	formulas	T170	C0282574
27898506	2289	2293	over	T081	C0392762
27898506	2299	2315	underestimations	T081	C0392762
27898506	2319	2322	UNa	T123,T196	C1973436
27898506	2327	2329	UK	T123,T196	C1971990
27898506	2330	2339	excretion	T039	C0221102
27898506	2367	2386	clinical evaluation	T058	C4084924
27898506	2390	2402	individual's	T098	C0237401
27898506	2407	2422	mean population	T081	C2347634
27898506	2423	2428	daily	T079	C0332173
27898506	2429	2432	UNa	T123,T196	C1973436
27898506	2437	2439	UK	T123,T196	C1971990
27898506	2440	2449	excretion	T039	C0221102